These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 24642256)
21. Topoisomerase I/II inhibition by a novel naphthoquinone containing a modified anthracycline ring system. Kennedy S; DiCesare JC; Sheaff RJ Biochem Biophys Res Commun; 2011 Apr; 408(1):94-8. PubMed ID: 21458415 [TBL] [Abstract][Full Text] [Related]
22. Pyrroloquinolinone-based dual topoisomerase I/II inhibitor. Dalla Via L; Marzaro G; Ferrarese A; Gia O; Chilin A Eur J Med Chem; 2014 Apr; 77():103-9. PubMed ID: 24631729 [TBL] [Abstract][Full Text] [Related]
23. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity. Poot M; Hiller KH; Heimpel S; Hoehn H Exp Cell Res; 1995 May; 218(1):326-30. PubMed ID: 7537696 [TBL] [Abstract][Full Text] [Related]
24. Study of molecular markers of resistance to m-AMSA in a human breast cancer cell line. Decrease of topoisomerase II and increase of both topoisomerase I and acidic glutathione S transferase. Lefevre D; Riou JF; Ahomadegbe JC; Zhou DY; Benard J; Riou G Biochem Pharmacol; 1991 Jun; 41(12):1967-79. PubMed ID: 1645555 [TBL] [Abstract][Full Text] [Related]
25. Type IA topoisomerase inhibition by clamp closure. Leelaram MN; Bhat AG; Godbole AA; Bhat RS; Manjunath R; Nagaraja V FASEB J; 2013 Aug; 27(8):3030-8. PubMed ID: 23612788 [TBL] [Abstract][Full Text] [Related]
26. Novel, potent, orally bioavailable and selective mycobacterial ATP synthase inhibitors that demonstrated activity against both replicating and non-replicating M. tuberculosis. Singh S; Roy KK; Khan SR; Kashyap VK; Sharma A; Jaiswal S; Sharma SK; Krishnan MY; Chaturvedi V; Lal J; Sinha S; Dasgupta A; Srivastava R; Saxena AK Bioorg Med Chem; 2015 Feb; 23(4):742-52. PubMed ID: 25614114 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of mycobacterial growth by plumbagin derivatives. Mathew R; Kruthiventi AK; Prasad JV; Kumar SP; Srinu G; Chatterji D Chem Biol Drug Des; 2010 Jul; 76(1):34-42. PubMed ID: 20456370 [TBL] [Abstract][Full Text] [Related]
28. Modulation of 4'-(9-acridinylamino)methanesulfon-m-anisidide-induced, topoisomerase II-mediated DNA cleavage by gossypol. Adlakha RC; Ashorn CL; Chan D; Zwelling LA Cancer Res; 1989 Apr; 49(8):2052-8. PubMed ID: 2539251 [TBL] [Abstract][Full Text] [Related]
29. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
30. Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB. Chaudhari K; Surana S; Jain P; Patel HM Eur J Med Chem; 2016 Nov; 124():160-185. PubMed ID: 27569197 [TBL] [Abstract][Full Text] [Related]
31. Physical and functional interactions between 3-methyladenine DNA glycosylase and topoisomerase I in mycobacteria. Yang Q; Huang F; Hu L; He ZG Biochemistry (Mosc); 2012 Apr; 77(4):378-87. PubMed ID: 22809157 [TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors. Altaf M; Miller CH; Bellows DS; O'Toole R Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470 [TBL] [Abstract][Full Text] [Related]
33. Physical and functional interaction between D-ribokinase and topoisomerase I has opposite effects on their respective activity in Mycobacterium smegmatis and Mycobacterium tuberculosis. Yang Q; Liu Y; Huang F; He ZG Arch Biochem Biophys; 2011 Aug; 512(2):135-42. PubMed ID: 21683681 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of human topoisomerases I and II by simocyclinone D8. Oppegard LM; Nguyen T; Ellis KC; Hiasa H J Nat Prod; 2012 Aug; 75(8):1485-9. PubMed ID: 22867097 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II. Zhuo ST; Li CY; Hu MH; Chen SB; Yao PF; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS Org Biomol Chem; 2013 Jun; 11(24):3989-4005. PubMed ID: 23657605 [TBL] [Abstract][Full Text] [Related]
36. Ligand-Based Virtual Screening for Discovery of Indole Derivatives as Potent DNA Gyrase ATPase Inhibitors Active against Pakamwong B; Thongdee P; Kamsri B; Phusi N; Taveepanich S; Chayajarus K; Kamsri P; Punkvang A; Hannongbua S; Sangswan J; Suttisintong K; Sureram S; Kittakoop P; Hongmanee P; Santanirand P; Leanpolchareanchai J; Spencer J; Mulholland AJ; Pungpo P J Chem Inf Model; 2024 Aug; 64(15):5991-6002. PubMed ID: 38993154 [No Abstract] [Full Text] [Related]
38. Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors. Jeankumar VU; Renuka J; Santosh P; Soni V; Sridevi JP; Suryadevara P; Yogeeswari P; Sriram D Eur J Med Chem; 2013; 70():143-53. PubMed ID: 24148991 [TBL] [Abstract][Full Text] [Related]
39. Deciphering the distinct role for the metal coordination motif in the catalytic activity of Mycobacterium smegmatis topoisomerase I. Bhat AG; Leelaram MN; Hegde SM; Nagaraja V J Mol Biol; 2009 Nov; 393(4):788-802. PubMed ID: 19733176 [TBL] [Abstract][Full Text] [Related]